Drug Profile
MitoExtra
Alternative Names: MitozytrexLatest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator SuperGen
- Class Antineoplastics; Beta-Cyclodextrins
- Mechanism of Action DNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Gastric cancer; Pancreatic cancer
Most Recent Events
- 15 Nov 2002 Registered for Gastric cancer in USA (Injection)
- 15 Nov 2002 Registered for Pancreatic cancer in USA (Injection)
- 24 Feb 1998 Preregistration for Solid tumours in USA (Injection)